Guardant Health Inc (GH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GH | ASND | BMRN | ||
| Company | Guardant Health Inc | Ascendis Pharma ADR | Biomarin Pharmaceuticals | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 108.00 | 230.51 | 63.09 | ||
| High | 113.78 | 230.51 | 64.25 | ||
| Low | 99.21 | 221.00 | 62.55 | ||
| Latest | 103.10 | 225.00 | 64.08 | ||
| Change | -3.28 | -5.21 | +0.66 | ||
| % Change | -3.08% | -2.26% | +1.04% | ||
| Volume | 5,102,200 | 950,400 | 3,634,200 | ||
| 20-Day Average Volume | 2,053,560 | 743,225 | 2,155,435 | ||
| Previous Close | 106.38 | 230.21 | 63.42 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 108.11 | 224.77 | 58.77 | ||
| 20-Day Raw Stochastic | 26.87% | 45.16% | 98.10% | ||
| 20-Day Relative Strength | 46.61 | 53.68 | 68.37 | ||
| Weighted Alpha | +109.74 | +47.00 | +2.86 | ||
| Today's Opinion | 56% Buy | 100% Buy | 88% Buy | ||
| Previous Opinion | 56% Buy | 100% Buy | 88% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 32% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.33% since 02/12/26 | +3.16% since 02/12/26 | +6.91% since 02/12/26 | ||
| Low | 99.21 on 02/20/26 | 213.02 on 02/13/26 | 59.38 on 02/17/26 | ||
| High | 113.78 on 02/20/26 | 230.98 on 02/19/26 | 64.25 on 02/20/26 | ||
| 1-Month | |||||
| %Chg | -10.25% since 01/20/26 | +4.37% since 01/20/26 | +13.80% since 01/20/26 | ||
| Low | 97.52 on 02/06/26 | 209.79 on 01/21/26 | 55.28 on 01/30/26 | ||
| High | 120.74 on 01/22/26 | 242.00 on 01/28/26 | 64.25 on 02/20/26 | ||
| 3-Month | |||||
| %Chg | +2.79% since 11/20/25 | +7.37% since 11/20/25 | +22.10% since 11/20/25 | ||
| Low | 96.28 on 12/18/25 | 188.08 on 01/12/26 | 50.90 on 12/15/25 | ||
| High | 120.74 on 01/22/26 | 242.00 on 01/28/26 | 64.25 on 02/20/26 | ||
| 6-Month | |||||
| %Chg | +76.24% since 08/20/25 | +16.70% since 08/20/25 | +10.56% since 08/20/25 | ||
| Low | 53.40 on 09/16/25 | 186.05 on 10/20/25 | 50.76 on 11/07/25 | ||
| High | 120.74 on 01/22/26 | 242.00 on 01/28/26 | 64.25 on 02/20/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 13,408,241 | 14,267,726 | 12,183,869 | ||
| Shares Outstanding, K | 126,041 | 61,977 | 192,114 | ||
| Annual Sales | 739,020,000 | 814,760,000 | 2,853,920,000 | ||
| Annual Net Income | -436,370,000 | -258,000,000 | 426,860,000 | ||
| Last Quarter Sales | 265,200,000 | 279,270,000 | 776,130,000 | ||
| Last Quarter Net Income | -92,730,000 | -42,910,000 | -30,740,000 | ||
| 60-Month Beta | 1.63 | 0.44 | 0.26 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.39 on 10/29/25 | -1.17 on 11/12/25 | 0.12 on 10/27/25 | ||
| Latest Earnings Date | 02/19/26 | 05/07/26 | 02/23/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 21.54 | ||